Lead
A scratch from a bug bite turned into a blister overnight. Two days later, the same lesion had appeared on the face. The name "impetigo" — sometimes translated from Japanese as "tobi-hi," meaning it "flies" from one spot to another — fits the course well. It is a common bacterial skin infection in summer, and particularly common in children.
The reason infection "flies" is straightforward: the fluid from lesions, and the broken-open blisters, spread bacteria on contact with skin. How antibiotics are used and what happens at home directly shapes how fast the infection resolves.
Two Types of Impetigo
Impetigo — technically called impetigo contagiosa — comes in two main forms.
Bullous impetigo (approximately 30% of cases): Staphylococcus aureus produces an exotoxin: a toxin secreted by bacteria into surrounding tissue, where it damages cells or disrupts normal function (exfoliative toxin: bacterial toxin that cleaves the protein holding skin layers together, causing the outer layer to peel off) that disrupts adhesion between epidermal cells, creating clear-to-yellow fluid-filled blisters. Itching is intense; when the blisters rupture, bacteria spread to adjacent skin. Fever is mild or absent [1,2].
Non-bullous (crusted) impetigo (the remaining ~70%): caused by S. aureus or group A <em>Streptococcus</em>: the bacterium behind strep throat; after a skin infection it can occasionally trigger kidney inflammation (post-streptococcal glomerulonephritis), or a mixed infection of both. After blisters rupture, honey-colored crusts form. Inflammation is more pronounced, and fever and lymph node swelling may accompany it [1,2].
What to watch for after treatment differs slightly between the two types. In the crusted form, streptococcus may be involved, and the complication clearly associated with streptococcal skin infection is not rheumatic fever but post-streptococcal glomerulonephritis: kidney inflammation caused by the immune response to a strep infection, appearing weeks later; typical signs are dark urine, swelling and high blood pressure [1,4].
Antibiotic Choice and Duration
For limited impetigo, a topical antibiotic (mupirocin and similar agents) is first-line and works about as well as oral treatment [1]. When lesions are extensive or topical treatment is impractical, an oral antibiotic is used — typically a first-generation cephalosporin such as cefalexin — usually for about 7 days [1].
A growing concern is community-acquired MRSA: methicillin-resistant <em>Staphylococcus aureus</em>, a strain resistant to most standard antibiotics and harder to treat (methicillin-resistant S. aureus). In the United States in the 2000s, MRSA was reported as the most common identifiable cause of skin and soft-tissue infections in emergency department patients [3]. The proportion varies widely by country and region, and when MRSA is involved, standard cephalosporins tend not to work. If you feel a usual course of antibiotics is not working as expected, asking the physician about culture and sensitivity testing is a reasonable step.
Use the full prescribed course even when symptoms improve: stopping early can let the infection come back, and treatment also helps limit spread to others [4]. At the same time, there is insufficient evidence that antibiotic treatment prevents post-streptococcal glomerulonephritis [1,4]. Because it can appear up to about three weeks after a skin infection, see a clinician if, after the impetigo has cleared, your child's urine turns cola-colored or reddish-brown or their face or eyelids become puffy [4]. More than 90% of children who develop it recover fully [4].
Preventing Spread Within the Household
Impetigo spreads primarily through direct contact with lesions and through shared objects — towels, clothing. Practical steps for limiting household spread:
Keep fingernails short. Scratching the lesions and then touching other skin is a primary route of spread. Short nails and discouraging scratching matter.
Do not share towels or clothing. Towels and clothing that have touched the affected area should ideally be washed separately from other family members' items.
Cover the lesions. A gauze dressing or bandage over the affected area reduces direct-contact transmission.
For daycare and school attendance, policies vary by facility — some say "covered lesions are fine"; others specify a number of days after starting antibiotics. Checking your facility's rules in advance avoids a scramble when the situation arises.
When to Seek Care Promptly
The following are signs that warrant an early visit to a clinician:
- Lesions spreading rapidly
- Fever above 38°C (100.4°F) or significant malaise
- No improvement with topical treatment after three days
- Lesions on or near the face or around the eyes
- Cola-colored or reddish-brown urine, or a puffy face or eyelids, in the weeks after the impetigo clears
In infants, extensive impetigo can occasionally progress to staphylococcal scalded skin syndrome: severe skin peeling triggered by staph exotoxins circulating in the bloodstream, resembling a burn; most common and dangerous in infants (SSSS), a generalized condition in which the skin reddens and peels across the body. If this develops, seek medical attention without delay.
Summary
Most cases of impetigo resolve quickly with appropriate antibiotics and household infection control. Understanding the two types, completing the prescribed course, and preventing secondary spread within the family are the three pillars of management. Keeping a dated record of lesion extent and progression is practically useful when communicating with a clinician — "is it spreading or contracting" is hard to convey verbally but easy to show.
References
- Hartman-Adams H, Banvard C, Juckett G. Impetigo: diagnosis and treatment. Am Fam Physician. 2014;90(4):229–235. PMID: 25250996.
- Nardi NM, Schaefer TJ. Impetigo. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2026 Jan. Bookshelf ID: NBK430974. PMID: 28613693.
- Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666–674. doi:10.1056/NEJMoa055356. PMID: 16914702.
- Centers for Disease Control and Prevention. Clinical Guidance for Post-Streptococcal Glomerulonephritis. https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/post-streptococcal-glomerulonephritis.html (accessed 2026-09-18).